BREO Drug Patent Profile
✉ Email this page to a colleague
When do Breo patents expire, and what generic alternatives are available?
Breo is a drug marketed by Glaxo Grp Ltd and is included in one NDA. There are four patents protecting this drug.
The generic ingredient in BREO is fluticasone furoate; vilanterol trifenatate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the fluticasone furoate; vilanterol trifenatate profile page.
DrugPatentWatch® Generic Entry Outlook for Breo
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BREO?
- What are the global sales for BREO?
- What is Average Wholesale Price for BREO?
Summary for BREO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for BREO |
| Drug Sales Revenues: | Drug sales revenues for BREO |
| DailyMed Link: | BREO at DailyMed |
